Bills · 2023-2024 Regular Session
Relating to: a pediatric cancer research tax credit. (FE)
Disease Franchise — Taxation Hospitals and health care facilities Income tax — Credit
- Introduced, stopped here
- Passes Assembly, not reached
- Passes Senate, not reached
- Governor signs, not reached
- Law, not reached
Unfamiliar terms? Glossary
What this bill does
Plain-language analysis by the nonpartisan Legislative Reference Bureau
This bill creates an income and franchise tax credit for contributions made by
a business entity to a pediatric cancer research institution. The bill requires the
institution to use the contribution exclusively and directly for pediatric cancer
research and defines a “pediatric cancer research institution” as a hospital or an
institution of higher education located in this state that is actively conducting
pediatric cancer research, as certified by the secretary of health services.
Under the bill, the maximum amount of the credit that an entity may claim in
any taxable year is $2,500,000. If the amount of the credit exceeds the entity's tax
liability, the entity does not receive a refund but, instead, may claim the remaining,
unused credit against the entity's tax liability in subsequent years.
What it would cost
Fiscal estimates filed by state agencies, as official PDFs
Sponsors
Full history
- Mar 14, 2023 · Assembly
Introduced by Representatives Bodden, Tusler, Behnke and Donovan; cosponsored by Senator Jacque
- Mar 14, 2023 · Assembly
Read first time and referred to Committee on State Affairs
- Mar 28, 2023 · Assembly
Fiscal estimate received
- Jan 10, 2024 · Assembly
Representative Gustafson added as a coauthor
- Apr 15, 2024 · Assembly
Failed to pass pursuant to Senate Joint Resolution 1